egtazic acid has been researched along with Acute Disease in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (40.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arba, F; Balami, JS; Buchan, AM; Kleinschnitz, C; Minnerup, J; Sutherland, BA | 1 |
| Bornstein, NM; Diener, HC; Kozak, A; Lampl, Y; Rosenberg, G; Schneider, D | 1 |
| Mahlberg, K; Pantzar, P; Tallberg, T; Tykkä, H | 1 |
| Goshima, M; Hori, Y; Kuroda, Y; Takase, K; Takeyama, Y; Ueda, T | 1 |
| Border, WA; Götze, O; Wilson, CB | 1 |
| Sjöholm, AG | 1 |
| Behar, J; Biancani, P; Billett, G; Hillemeier, C; Nissensohn, M; Rhim, BY; Szewczak, S | 1 |
| Sahai, A; Sandler, RS; Shayman, JA; Tannen, RL; Xu, G | 1 |
| Srimal, RC; Srivastava, R | 1 |
| Chapman, AJ; Clarridge, JE; Jonsson, S; Musher, DM; Wallace, RJ | 1 |
1 review(s) available for egtazic acid and Acute Disease
| Article | Year |
|---|---|
Neuroprotection for ischaemic stroke: translation from the bench to the bedside.
Topics: Acute Disease; Animals; Benzenesulfonates; Brain Ischemia; Chelating Agents; Clinical Trials as Topic; Combined Modality Therapy; Diffusion of Innovation; Disease Models, Animal; Drug Evaluation, Preclinical; Egtazic Acid; Hematopoietic Cell Growth Factors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypothermia, Induced; Magnesium; Minocycline; NADPH Oxidases; Neuroprotective Agents; Pregnatrienes; Serum Albumin; Stroke; Thrombolytic Therapy; Translational Research, Biomedical | 2012 |
1 trial(s) available for egtazic acid and Acute Disease
| Article | Year |
|---|---|
DP-b99, a membrane-activated metal ion chelator, as neuroprotective therapy in ischemic stroke.
Topics: Acute Disease; Aged; Aged, 80 and over; Brain; Brain Infarction; Brain Ischemia; Cell Membrane; Chelating Agents; Cytoprotection; Double-Blind Method; Egtazic Acid; Emergency Medical Services; Female; Humans; Injections, Intravenous; Ions; Male; Metals; Middle Aged; Neuroprotective Agents; Placebos; Treatment Outcome | 2008 |
8 other study(ies) available for egtazic acid and Acute Disease
| Article | Year |
|---|---|
Phospholipase A2 inhibitors and their possible clinical use in the treatment of acute pancreatitis.
Topics: Acute Disease; Adult; Aged; Chelating Agents; Edetic Acid; Egtazic Acid; Female; Humans; Male; Middle Aged; Pancreatitis; Pentetic Acid; Phospholipases; Phospholipases A; Phospholipases A2; Phytic Acid | 1980 |
Pancreatitis-associated ascitic fluid increases intracellular Ca(2+) concentration on hepatocytes.
Topics: Acute Disease; Animals; Ascitic Fluid; Calcium; Cells, Cultured; Dogs; Egtazic Acid; Liver; Male; Multiple Organ Failure; Pancreatitis; Platelet Activating Factor; Rats; Rats, Wistar; Verapamil | 2000 |
Nephritic factor: Description of a new quantitative assay and findings in glomerulonephritis.
Topics: Acute Disease; Complement C3; Complement C5; Complement System Proteins; Dose-Response Relationship, Drug; Egtazic Acid; Fluorescent Antibody Technique; gamma-Globulins; Glomerulonephritis; Hot Temperature; Humans; Immune Complex Diseases; Inulin; Kidney Glomerulus; Magnesium; Streptococcal Infections | 1976 |
Complement components and complement activation in acute poststreptococcal glomerulonephritis.
Topics: Acute Disease; alpha 1-Antitrypsin; Antibodies, Bacterial; Binding Sites; C-Reactive Protein; Complement C1; Complement C3; Complement System Proteins; Egtazic Acid; Glomerulonephritis; Humans; Orosomucoid; Streptococcus | 1979 |
Acute experimental esophagitis impairs signal transduction in cat lower esophageal sphincter circular muscle.
Topics: Acute Disease; Animals; Calcium; Cats; Cyclic AMP; Cyclic GMP; Egtazic Acid; Esophagitis; Esophagogastric Junction; Female; In Vitro Techniques; Inositol Phosphates; Male; Signal Transduction | 1992 |
Signal transduction events whereby PGF2 alpha inhibits the ammoniagenic response to acute acidosis.
Topics: Acidosis; Acute Disease; Alanine; Amiloride; Ammonia; Animals; Calcium Channel Blockers; Cell Line; Dinoprostone; Egtazic Acid; Protein Kinase C; Signal Transduction; Tetradecanoylphorbol Acetate | 1992 |
Amplification of platelet response during acute inflammation in rats.
Topics: Acute Disease; Animals; Egtazic Acid; Gallic Acid; Heparin; Inflammation; Male; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Platelet Aggregation; Platelet Factor 4; Rats | 1990 |
Development of bactericidal antibody during Branhamella catarrhalis infection.
Topics: Acute Disease; Adult; Antibodies, Bacterial; Blood Bactericidal Activity; Bronchitis; Convalescence; Cross Reactions; Egtazic Acid; Hot Temperature; Humans; Neisseria; Respiratory Tract Infections; Sinusitis | 1985 |